Original Research Online Publishing Date: | ||||||||||||
Comparative study of safety and efficacy of omeprazole, lansoprazole, and rabeprazole in triple therapy for eradication of Helicobacter pylori in peptic ulcer patients in Indian population Padmavathi Devagudi, Mabu Shareef, Naser Ashraf Tadvi.
|
How to Cite this Article |
Pubmed Style Padmavathi Devagudi, Mabu Shareef, Naser Ashraf Tadvi. Comparative study of safety and efficacy of omeprazole, lansoprazole, and rabeprazole in triple therapy for eradication of Helicobacter pylori in peptic ulcer patients in Indian population. Natl J Physiol Pharm Pharmacol. 2017; 7(3): 250-254. doi:10.5455/njppp.2017.7.0926330092016 Web Style Padmavathi Devagudi, Mabu Shareef, Naser Ashraf Tadvi. Comparative study of safety and efficacy of omeprazole, lansoprazole, and rabeprazole in triple therapy for eradication of Helicobacter pylori in peptic ulcer patients in Indian population. https://www.njppp.com/?mno=241646 [Access: March 14, 2024]. doi:10.5455/njppp.2017.7.0926330092016 AMA (American Medical Association) Style Padmavathi Devagudi, Mabu Shareef, Naser Ashraf Tadvi. Comparative study of safety and efficacy of omeprazole, lansoprazole, and rabeprazole in triple therapy for eradication of Helicobacter pylori in peptic ulcer patients in Indian population. Natl J Physiol Pharm Pharmacol. 2017; 7(3): 250-254. doi:10.5455/njppp.2017.7.0926330092016 Vancouver/ICMJE Style Padmavathi Devagudi, Mabu Shareef, Naser Ashraf Tadvi. Comparative study of safety and efficacy of omeprazole, lansoprazole, and rabeprazole in triple therapy for eradication of Helicobacter pylori in peptic ulcer patients in Indian population. Natl J Physiol Pharm Pharmacol. (2017), [cited March 14, 2024]; 7(3): 250-254. doi:10.5455/njppp.2017.7.0926330092016 Harvard Style Padmavathi Devagudi, Mabu Shareef, Naser Ashraf Tadvi (2017) Comparative study of safety and efficacy of omeprazole, lansoprazole, and rabeprazole in triple therapy for eradication of Helicobacter pylori in peptic ulcer patients in Indian population. Natl J Physiol Pharm Pharmacol, 7 (3), 250-254. doi:10.5455/njppp.2017.7.0926330092016 Turabian Style Padmavathi Devagudi, Mabu Shareef, Naser Ashraf Tadvi. 2017. Comparative study of safety and efficacy of omeprazole, lansoprazole, and rabeprazole in triple therapy for eradication of Helicobacter pylori in peptic ulcer patients in Indian population. National Journal of Physiology, Pharmacy and Pharmacology, 7 (3), 250-254. doi:10.5455/njppp.2017.7.0926330092016 Chicago Style Padmavathi Devagudi, Mabu Shareef, Naser Ashraf Tadvi. "Comparative study of safety and efficacy of omeprazole, lansoprazole, and rabeprazole in triple therapy for eradication of Helicobacter pylori in peptic ulcer patients in Indian population." National Journal of Physiology, Pharmacy and Pharmacology 7 (2017), 250-254. doi:10.5455/njppp.2017.7.0926330092016 MLA (The Modern Language Association) Style Padmavathi Devagudi, Mabu Shareef, Naser Ashraf Tadvi. "Comparative study of safety and efficacy of omeprazole, lansoprazole, and rabeprazole in triple therapy for eradication of Helicobacter pylori in peptic ulcer patients in Indian population." National Journal of Physiology, Pharmacy and Pharmacology 7.3 (2017), 250-254. Print. doi:10.5455/njppp.2017.7.0926330092016 APA (American Psychological Association) Style Padmavathi Devagudi, Mabu Shareef, Naser Ashraf Tadvi (2017) Comparative study of safety and efficacy of omeprazole, lansoprazole, and rabeprazole in triple therapy for eradication of Helicobacter pylori in peptic ulcer patients in Indian population. National Journal of Physiology, Pharmacy and Pharmacology, 7 (3), 250-254. doi:10.5455/njppp.2017.7.0926330092016 |